Optimizing Management of MAC Lung Disease with Guideline-Based Therapy - CMEducation Resources symposium
Insmed Gets FDA Approval for First Mycobacterium Avium Complex (MAC) Lung Disease Therapy - Equities News
Southwest Journal of Pulmonary, Critical Care and Sleep - Imaging - Medical Image of the Week: MAC Infection
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK | BMJ Open Respiratory Research
Nontuberculous Mycobacteria (NTM)
MAC Lung Infections in CF Best Treated When Specific Bacterial Species Known, Study Finds
Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings | European Respiratory Society
Cureus | A Case of Isolated Pulmonary Mycobacterium Avium Complex Being the First Presentation of a Newly Diagnosed HIV/AIDS | Article
JCM | Free Full-Text | Computed Tomography in Adults with Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: Typical Imaging Findings
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases | PLOS Neglected Tropical Diseases
Frontiers | Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?
Rapid development of pulmonary Mycobacterium avium infection during chemoradiotherapy followed by durvalumab treatment in a locally advanced NSCLC patient - Lung Cancer
First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease | Scientific Reports